Eastman Chemical Company

NYSE:EMN

Chemicals

Basic Materials
$62.36 -1.58%

-$1.16 today

Market cap
$7.13B
Beta
1.07
P/E (TTM)
20.6
EPS (TTM)
$3.50
Dividend yield
4.65%
52W Low $56.11High $83.47

Volume 1.38M

Average 1.33M

EMN EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Eastman Chemical CompanyNYSE: EMN

EBITDA · Q2 FY2026 · quarter ended Jun 2026

EBITDA growth accelerates

Q2 FY2026 EBITDA of $442M rose 25.6% year over year, ahead of the -26.3% change in trailing-twelve-month EBITDA. Sequentially, it rose 39.9% from the prior quarter. Over 3 fiscal years it compounded at -7.6% a year.

Context

  • EBITDA amounted to 14.7% of revenue in FY2025, down 4.5 pp from a year earlier.
  • EBITDA increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 11 analysts of $1.61B (+24.8%) for the fiscal year ending Dec 2026, a step up from the -28.5% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$442M+39.9% QoQ
Last fiscal yearDec 2025
$1.29B-28.5% YoY
LTMJun 2026
$1.27B-26.3% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+25.6%+44.5%+18.9 pp
1 year-28.5%+24.8%+53.3 pp
3-year CAGR-7.6%+11.6%+19.2 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
1.29B USD
Year-over-year change
-28.5%
4-year CAGR
-8.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How EMN compares with its peers on the latest reported figures

  • EMN's LTM Jun 2026 EBITDA of $1.27B is the 2nd highest of the 11 companies compared; the peer median is $423M.
  • Its year-over-year change of -26.3% is the 9th highest of 11, against a peer median of -3.4%.
  • EBITDA amounts to 14.3% of revenue for EMN, versus a peer median of 10.9%.
EMN Competitors Peer median
EBITDA for EMN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DOWDow Inc.LTM Sep 2026$3.51B +17.7%-50.0%8.2%
EMNEastman Chemical CompanyLTM Jun 2026$1.27B -26.3%-7.6%14.3%
CBTCabot CorporationLTM Jun 2026$690M -14.9%+13.9%19.0%
WLKWestlake CorporationLTM Sep 2026$684M +41.6%—6.0%
AVNTAvient CorporationLTM Sep 2026$506.9M +19.1%+16.5%14.8%
ESIElement Solutions IncLTM Sep 2026$466M -1.9%-13.5%13.4%
ASHAshland Inc.LTM Jun 2026$380M +176.5%—20.6%
IOSPInnospec Inc.LTM Jun 2026$181M -12.7%-7.0%9.8%
SCLStepan CompanyLTM Mar 2026$139.93M -27.5%-10.3%6.0%
NGVTIngevity CorporationLTM Sep 2026$136.5M -4.9%-56.0%12.1%
HUNHuntsman CorporationLTM Mar 2026$124M -68.4%-44.9%2.2%
Peer median (excluding EMN) $423M-3.4%-11.9%10.9%

Competitors are the stored peer set for EMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue10.48B10.54B9.2B9.38B8.75B
Cost of Revenue7.97B8.48B7.14B7.09B6.91B
Gross Profit2.52B2.06B2.06B2.29B1.84B
Gross Margin24.0%19.5%22.4%24.4%21.1%
Research & Development254M264M239M250M255M
Selling, General & Admin795M708M727M664M658M
Operating Expenses1.05B972M966M914M913M
Depreciation & Amortization538M477M498M509M513M
EBITDA1.81B1.64B1.81B1.8B1.29B
EBITDA Margin17.3%15.5%19.6%19.2%14.7%
Operating Income1.47B1.08B1.1B1.38B931M
Operating Margin14.0%10.3%11.9%14.7%10.6%
Interest Income3M6M10M16M0
Interest Expense192M188M225M216M208M
Other Income / Expenses(387M)(107M)(9M)(298M)(363M)
Income Before Tax1.08B977M1.09B1.08B568M
Pre-Tax Margin10.3%9.3%11.8%11.5%6.5%
Income Tax Expense215M181M191M170M93M
Net Income857M793M894M905M474M
Net Margin8.2%7.5%9.7%9.6%5.4%
EPS (Basic)6.356.427.547.754.13
EPS (Diluted)6.256.357.497.674.10
Weighted Avg Shares134.9M123.5M118.6M116.7M114.7M
Weighted Avg Shares (Diluted)137.1M124.9M119.4M117.9M115.6M

Eastman Chemical Company

NYSE:EMN

Intrinsic Alpha fair value

Locked

Current Price

$62.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.